Aesica, the global contract development and manufacturing organization, has appointed two senior business development positions. Detlef Behrens has been appointed to the role of vice president, business development, finished dose with Sven Wrabletz joining as business development director, finished dose.
Detlef has overall responsibility for business development and for finished dose services, covering formulation development, bulk manufacturing, and packaging with a full international remit across the group. Sven is also responsible for finished dose development, manufacturing, and packaging but with a geographic remit covering Northern Germany, Benelux, and Eastern Europe. Both positions are based in Germany. Detlef reports directly to Ian Muir, managing director, finished dose. Prior to working for Aesica, Detlef held senior business development roles at Piramal and Next Pharma. As a qualified pharmacist, he holds a PhD, and is a board member and member of the Education Committee of DCAT.
Sven Wrabletz holds a diplom-betriebswirt (FH) and a bachelor of arts in international business administration and joined Aesica from Clondalkin, a packaging specialist.